A research team at National Sun Yat-sen University has developed a non-invasive imaging technology designed for diagnosing ...

Telix CEO Christian Behrenbruch hinted changes to the US Food and Drug Administration have hampered approval of its new brain ...

Telix (ASX:TLX) has copped a sharp jab on Monday as the FDA says its drug TLX101-CDx, AKA Floretyrosine, can’t be accepted ...

Telix has been shocked by the US Food & Drug Administration's rejection of marketing approval for its brain cancer diagnostic ...

Researchers have developed an AI system that predicts brain tumor recurrence in children using sequential MRI scans. By ...